Journal of Cardiovascular Disease Research
FORMULATION AND DEVELOPMENT OF ANTITUBERCULAR DRUG LOADED NANOPARTICLE FOR THE TREATMENT OF TUBERCULOSIS
Yashwant Singh, Ritika Singh, Dhirendra Pratap Singh, Mark Masih, Shabenoor Siddiqui
JCDR. 2023: 1808-1835
Abstract
Multidrug-resistant TB is on the rise, which has brought to light both the need for the creation of novel TB drug therapies and the drawbacks of the present conventional TB treatment, particularly the extended duration of the treatments and the difficulties with patient compliance. In order to cure tuberculosis, the current work's objective was to produce gelatin nanoparticles carrying rifabutin. In this study, rifabutin-loaded gelatin nanoparticles (GNP) were created as a delivery system using a double desolation process.
» PDF